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Females with exacerbations of Chronic Obstructive Pulmonary Disease now account for one 
half of all hospital admissions for that condition and rates have been increasing over the last 
few decades. Differences in presentations of disease between genders have been shown in 
several conditions and this study explores whether there are inter gender biases in probable 
diagnoses in those suspected to have COPD.  
 
Methods 
445 individuals with a provisional diagnosis by their General Practitioner of “suspected 
COPD” or “definite COPD” were referred to a community Respiratory Assessment unit 
(CRAU) for tests including spirometry.   Gender, demographics, respiratory symptoms and 
respiratory medical history were recorded. The provisional diagnoses were compared with 
the final diagnosis made after spirometry and respiratory specialist nurse review and the 
provisional diagnosis was  either confirmed as correct or refuted as unlikely.   
 
Results 
Significantly more men (87.5%) had their diagnosis of “definite COPD” confirmed   compared 
to 73.9% of women (p=0.021).  When the GP suggested a provisional diagnosis of “suspected 
COPD” (n=265) at referral, this was confirmed in 60.9% of men and only 43.2% of women 
(p=0.004). There was a different symptom pattern between genders with women being 
more likely to report allergies, symptoms starting earlier in life, and being less likely than 
men to report breathlessness as the main symptom.   
 
Conclusions 
These results may suggest a difference between genders in some of the clinical features of 
COPD and a difference in likelihood of a GPs provisional diagnosis of COPD being correct.  







Respiratory disease accounts for approximately 20% of all consultations in primary care, and 
is the second most common reason for admission to hospitals [1]. Much of the morbidity 
and mortality related to such diseases results from exacerbations. Frequent exacerbations of 
Chronic Obstructive Pulmonary Disease (COPD) are associated with more rapid decline in 
lung function [2].  Improving the identification of those with long term conditions such as 
COPD and ensuring effective management is crucial to minimise the burden of long term 
conditions. In the United Kingdom, this includes schemes such as the Quality Outcomes 
Framework (QOF) where general practices are rewarded for achieving targets in clinical 
indicators to improve diagnosis, build disease registers and provide interventions for those 
with long term conditions.    
 
QOF points are given for confirmation of COPD with spirometry and annual reviews for those 
with COPD and asthma.  This has ensured that more general practitioners are offering 
spirometry, but studies have shown that few nurses undertaking spirometry had undertaken 
training and few diagnosing COPD had specialist training [3, 4]  
 
Current UK guidelines all highlight the importance of accurate diagnosis of COPD through a 
combination of history taking, examination, spirometry and specialist review where needed 
[5].  A Community Respiratory Assessment Unit (CRAU) was established in 2004 in West 
London to provide diagnostic support to primary care physicians working within the 
Hammersmith and Fulham area [6].  An audit of the first four years of the programme has 
been published [7] and patients were referred from over 20 different general practices. The 
main driver for referral was likely to be the QOF process and it is not possible to determine 
how representative those referred to CRAU are of others attending those practices. 
In cardiac cases Mosca et al have shown that clinicians often fail to recognise cardiovascular 
risk in women [9].  Similarly in the field of lung disease Chapman et al [10] showed in 2001, 
using hypothetical scenarios, that COPD was given as the probable diagnosis significantly 
more often in men compared to  women (58% vs 42%; p<0.05).  This study has not been 
updated to see if this trend still exists  and has not been evaluated in a real population study.   
In recent years the worldwide prevalence of COPD has been growing faster for women 
compared to men in many countries such as the USA  [11].  Admissions to hospital for 
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women with exacerbations of COPD have been steadily increasing and in the 2014 National 
COPD Audit in England and Wales women accounted for 51% of the admissions [8].  
Infantino et al [12] suggest that women may not experience typical COPD symptoms.  We 
have therefore explored which biases, if any, currently inform GP predicted diagnoses of 
COPD in men and women.   
 
Methods  
Gender, demographics, respiratory symptoms and history were examined for patients 
referred by a GP to a community Respiratory Assessment unit for diagnostic spirometry 
(CRAU) with a provisional diagnosis of “suspected COPD” or “definite COPD” over a 4 year 
period.  The provisional diagnoses were compared with the final diagnosis after spirometry 
and respiratory specialist nurse review. Details of previous analyses from the CRAU database 
have been published elsewhere [6,7].   
 
The CRAU consultation consisted of the following elements: obtaining a Respiratory history, 
measurement of Oxygen saturation, measurement of exhaled CO in smokers, spirometry +/- 
reversibility testing,  checking of medications and inhaler technique, smoking cessation 
advice and advice regarding lifestyle changes (i.e nutrition, exercise). When, as a result of 
the consultation and investigations a specific diagnosis was explicit, appropriate self-
management education  was provided.  Spirometry was carried out following a standard 
operational procedure based on key national and international guidance [3] using height, 
weight, ethnicity, gender and age.  Usual exclusion criteria were used (e.g. unstable angina, 
haemoptysis, active tuberculosis or other respiratory infection, recent thoracic surgery) and 
three technically acceptable manoeuvres were required, (two within 100ml) to ensure 
reproducibility criteria, and diagnoses of COPD suggested according to GOLD criteria in place 
at the time[15].  Proformas were developed for GP referral, nurse consultation, and 
diagnostic reports to primary care. Referral forms required GPs to suggest a referral 
diagnosis by selecting one from a list which consisted of: suspected or confirmed asthma, 
suspected or confirmed COPD, unexplained breathlessness, and cough. Nurse history sheets 
identified current medications, past medical, family and smoking history as well as current 
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respiratory symptoms and their duration.   Data from the GP referral, nursing history sheets, 
spirometry measurements and the GP report were entered in to SPSS for analysis. 
 
The confirmed diagnosis, GP letter, spirometry results, and nursing history sheets were 
reviewed by a respiratory physician and compared to the original GP referral suspected 
diagnosis.  On the basis of this data, a decision was made whether the GP referral diagnosis 
was accurate or incorrect.   
 
Statistical analysis 
All statistical analysis was carried out using the software program SPSS (Version 20.0). For all 
analyses, Pearson chi square tests and independent t tests were used to look at gender 
differences and differences  between confirmed and refuted diagnoses.   A statistical 





Between January 2005 and December 2008, 1,156 referrals were received by the 
Community Respiratory Assessment Unit. COPD was the single most prevalent referral 
indication and this report focuses on the 445 GP referrals for “suspected” or “definite COPD” 
(221 males, 224 females).  These referrals were reviewed and a comparison made between 
GP referral diagnosis and final diagnosis from the unit for both males and females. 
Significant differences were found in the proportion of those with a confirmed “correct” 
referral diagnosis of COPD between men and women (men [72%] versus [56%] in women, 
p=0.001). When the GP suggested a provisional diagnosis of “definite COPD” (n=180) at 
referral, this was confirmed in 87.5% of men and 73.9% of women (p=0.021).  When the GP 
suggested a provisional diagnosis of “suspected COPD” (n=265) at referral, this was 
confirmed in 60.9% of men and only 43.2% of women (p=0.004). 
 
Patients with a suggested GP diagnosis of “definite COPD” (n=180) 
The respiratory medical history taken from these patients showed that women with a 
referral diagnosis of definite COPD (n=180), irrespective of final outcome tended to  be more 
likely to report a history of allergy symptoms compared to men (30.4% versus  17.0%; 
p=0.099). Although similarly not statistically significant  women  referred with definite COPD 
(not necessarily confirmed) were also less likely to report progressive breathlessness as their 
main symptom compared to men (women  58.7%, versus men 73.8%; p=0.098).     
 
Gender differences in symptoms between males and females where provisional diagnosis of 
“definite COPD” was confirmed (n=145). 
Of those with a confirmed CRAU diagnosis of COPD after a referral with definite COPD (Table 
1), women were more likely to report symptoms of allergy than men  (women 29%, versus 
men 19%; p=0.001).  Women were also more likely to describe symptoms which  were 
variable from day to day (women  25% versus men 12%; p=0.050).   
 
Gender differences between symptoms in males and females where provisional diagnosis of 
“definite COPD”  was refuted (n=35) 
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As part of the medical history individuals were asked if they had any allergies, and women 
who had a diagnosis of COPD refuted  tended to report allergies more than men (women  
33% versus men  0 % p=0.067).   The majority of women in this group had no evidence of 
airways narrowing (75%). The other 6 individuals were classed as having restrictive 
spirometry (12.5%)  or were thought to have asthma (12.5%).  Of the 11 males 45.5% were 
on inhaled medication (excluding SABAs) at the time of referral, compared to 58%  of 
women.  
 
Patients with suggested GP diagnosis of “suspected COPD”(n=265) 
There were significant differences in the number of women compared to men who had a 
diagnosis of COPD confirmed after the CRAU consultation (women , 43.2% versus men  
60.9%, p=0.004).  Females with suspected COPD were more likely to report allergies (women  
32.6%, versus men  15%, p=0.004).   
 
Gender differences in symptoms between males and females where provisional diagnosis of 
“suspected COPD” was confirmed (n=138) 
 
Females with a confirmed diagnosis of COPD had a higher prevalence of allergies compared 
to men (female  40% versus men  13.5% p=0.001).  They were also more likely to have had a 
family or personal history of atopic disease (women, 56% versus men  37% p=0.019) and 
were more likely to have symptoms starting later in life (5th,6th decade) (women  89.5% 
versus men 75%, p=0.043) 
 
Gender differences in symptoms between males and females where provisional diagnosis of 
“suspected COPD” was refuted  (n=127). 
 
Women in this group had more symptoms of cough (women, 23% versus  men 11.5%, 
p=0.046) and worse symptoms in the morning (women 28% versus men  25% p=0.025).   Of 
those women with a refuted COPD diagnosis, 79% had spirometry results showing no 
airways narrowing, 13% had restrictive spirometry and 8% had a diagnosis of asthma.  In this 
sub group, (women with a refuted diagnosis for suspected COPD), 79% were smokers or ex-
smokers, compared to 91%  of women with their suspected diagnosis confirmed.   27% of 
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males were on inhaled medication (excluding SABAs);, similar levels were evident in females, 
(28%). 
 
A smaller number of men did not have the diagnosis of suspected COPD confirmed (39%) 
and these were likely to have either spirometry with no evidence of airways narrowing 
(69%), restrictive spirometry (15%), a non-respiratory cause (8%,) or asthma (6%).  In this 
group 85% of men smoked  compared to 95%  of those with confirmed COPD.    
 
Table 3 shows the likelihood of a GPs suspected or definite diagnosis of COPD being 
confirmed as correct, the results are much lower for those referred with suspected COPD 
(0.52) compared to those referred to with definite COPD (0.81). The results are also much 
lower for females (0.42 suspected COPD; 0.73 for definite COPD) than for men (0.61 






This study examined 445 referrals from general practice to a community respiratory 
assessment unit with either suspected or definite COPD.  Amongst GP referrals with 
“suspected” and “definite” COPD, there were significant differences in final diagnosis 
between men and women after spirometry. In a review by  Aryal  et al, gender differences in 
the clinical presentation of COPD are discussed showing that women were more likely to  
report dyspnoea and more exacerbations compared to men [13].  In our study women were 
more likely to have a GP diagnosis of COPD amended after spirometry with no spirometric 
evidence of airway narrowing being found with the diagnosis being thought to be a non-
respiratory condition.  Amongst those referred with a suggested definite diagnosis of COPD 
this diagnosis was confirmed in 88% of men and 74% of women.  
 
Where the GP diagnosis of COPD (either suspected or definite) was confirmed, there was a 
higher reported prevalence of allergies in the women’s respiratory medical histories, 
compared to the men.   Women referred with definite COPD but in whom that diagnosis was 
refuted also had significantly higher prevalence of allergies when compared to  men. One 
possible explanation for this could be the fact that these women actually had asthma, but 
with normal spirometry at the time of testing,  but we have no follow up data on the 
eventual diagnosis of those in whom we were unable to confirm the GPs initial suspected 
diagnosis. 
 
High levels of smoking were evident in both groups perhaps influencing GPs attitudes 
towards this diagnosis, as opposed to other possible diagnoses particularly in women.  
Infantino et al [10] suggest that women may not experience typical COPD symptoms.  In the 
current study women appear to have a different symptom profile for COPD, and they were 
more likely to present with allergies and a family history of allergic disease, to present later 
in life than men, and less likely  to present with breathlessness as the main symptom. An 
explanation for this is not immediately apparent but one possible hypothesis would be that 
more women than men in this study had the more recently described  overlap syndrome, 
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where individuals, usually over the age of 40 present with symptoms of chronic airways 
disease with features of both asthma and COPD [14]. 
 
In line with current guideline recommendations a diagnosis of COPD was refuted if no 
evidence of airway narrowing was present.  This of course depends upon the current 
classification of disease and occasionally patients with COPD present not with airway 
narrowing but with a productive cough and similarly some may present with breathlessness 
due to emphysema which can occur rarely with normal spirometry. Aberrant results may 
also occur if the patient is already on treatment at the time of referral for diagnostic 
assessment. A significant proportion of those with a refuted diagnosis of COPD were on 
inhaled medication and a proportion of these with no evidence of airways narrowing could 
instead have treated asthma.   As the allergy signal seen amongst females in this dataset 
does not seem to be a strong differentiator of accurate diagnosis it is possible that the 
confirmed COPD group could contain those with asthma – COPD overlap syndrome (ACOS) 
or fixed airflow obstruction due to chronic asthma with or without smoking.   
 
We cannot tell how representative the patients in this study are of those with COPD in 
general or how their history and symptom patterns are or are not typical of other patients in 
general practice. However this study suggests, as others have, that there are gender 
differences in the presentation and clinical profile of those with respiratory disease,   but the 
clinical message is clear;  the need for objective testing prior to the diagnosis of COPD  is 






This study found significant differences between men and women in confirmed diagnoses of 
COPD after referral for suspected or definite COPD.  Women were more likely to have a GP 
diagnosis of COPD which was amended after spirometry.  High levels of smoking were 
evident in both groups perhaps influencing GPs towards this diagnosis, as opposed to other 
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Table 1 Results for correct /incorrect diagnosis for definite COPD 
 
Definite COPD n=180 
 
Correct diagnosis (n=145) 
 
Refuted diagnosis (n=35) 
 
 
Males Females P value Males Females P value 
N 77 68  11 24  
Age in years (SD) 67.4 (11.7) 70.7 (10.5) 0.067 63.7 (12.4) 70.0 (10.7) 0.134 
BMI (SD) 26.3 (5.8) 27.1 (9.7) 0.555 24.5 (4.7) 27.1 (5.8) 0.222 
RCP score* (SD) 3.9 (0.9) 3.9 (1.1) 0.119 3.7 (1.3) 3.6 (1.12) 1.000 
Pre-bronchodilator FEV1 FVC (SD) 48.5 (12.4) 52.9 (12.7) 0.064 72.4 (8.63) 69.5 (12.3) 0.512 
Past medical history           
Allergies, % 15 19.5 20 29.4 0.001 0 0.0 8 33.3 0.027 
Cough present, % 9 11.7 15 22.0 0.176 2 18.2 6 25 0.623 
Respiratory symptoms dating back 
to childhood, % 
13 16.9 18 26.5 0.284 2 18.2 6 25 1.000 
Symptoms vary from day to day 
and time to time, % 
9 11.7 17 25 0.050 3 27.3 6 25 0.852 
Symptoms worse in the morning, 
patient wakes prematurely, % 
12 15.6 12 17.7 0.873 3 27.3 5 20.83 0.573 
Has a family or personal history of 
atopic  disease including asthma, 
hayfever, and eczema, % 
24 31.2 26 38.2 0.580 5 45.5 15 62.5 0.628 
Symptoms started in 5th, 6th or 
7th decade, % 
61 79.2 51 75 0.846 8 72.7 19 79.2 0.685 
Main symptom is progressive 
breathlessness on exertion over 
the last 1-3 years, % 
56 72.7 39 57.4 0.175 9 81.8 15 62.5 0.526 
Patient is a smoker or ex-smoker, % 71 92.2 61 89.7 0.887 10 90.9 21 87.5 1.000 
* This is the score from the  Royal College of Physicians 'three questions' used in asthma reviews [16] 
Pearsons chi squared tests and independent t tests were used significance is P<0.05, Fischer’s exact test reported when the cell count was 
below the expected number 
15 
 
Table 2 Results for correct/incorrect diagnosis for suspected COPD 
 
 
Suspected COPD n=265 
Correct diagnosis (n=138) 
 





Females P value Males Females P value 
N 81 57  52 75  
Age in years (SD) 65.4 (11.2) 68.4 (10.3) 0.111 59.9 (11.9) 65.8 12.9) 0.009 
BMI (SD) 26.5 ( 6.9) 25.9 (6.5) 0.692 26.9 ( 4.9) 27.9 (7.2) 0.379 
RCP score* (SD) 4.1 ( 0.6) 3.9 (1.0) 0.315 3.7 ( 1.2) 3.8 (1.0) 0.573 
Pre-bronchodilator FEV1 FVC (SD) 53.2 (11.2) 56.1 (9.2) 0.108 72.7 (13.1) 73.0 (8.5) 0.908 
Past medical history           
Allergies, % 11 13.6 23 40.4 0.001 9 17.3 20 26.7 0.506 
Cough present, % 20 24.7 8 14.0 0.280 6 11.5 17 22.7 0.046 
Respiratory symptoms dating back 
to childhood, % 
19 23.5 18 31.6 0.289 9 17.3 11 14.7 0.905 
Symptoms vary from day to day 
and time to time, % 
16 19.8 11 19.3 1.000 18 34.6 20 26.7 0.375 
Symptoms worse in the morning, 
patient wakes prematurely, % 
21 25.9 11 19.3 0.419 13 25.0 21 28.0 0.025 
Has a family or personal history of 
atopic  disease including asthma, 
hayfever, and eczema, % 
30 37.0 32 56.1 0.019 19 36.5 32 42.7 0.707 
Symptoms started in 5th, 6th or 
7th decade, % 
61 75.3 51 89.5 0.043 34 65.4 56 74.7 0.464 
Main symptom is progressive 
breathlessness on exertion over 
the last 1-3 years, % 
45 55.6 40 70.2 0.211 32 61.5 45 60.0 0.705 
Patient is a smoker or ex-smoker, % 77 95.1 52 91.2 0.488 45 86.5 59 78.7 0.190 
 
 * This is the score from the  Royal College of Physicians 'three questions' used in asthma reviews [16] 
Pearsons chi squared tests and independent t tests were used significance is P<0.05, Fischer’s exact test reported when the cell count was 
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